Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study.
R B WarrenAntonia M MarsdenB TomensonKayleigh J MasonM M SolimanA D BurdenN J ReynoldsD StockenR EmsleyC E M GriffithsC Smithnull nullPublished in: The British journal of dermatology (2018)
Psoriasis phenotype and potentially modifiable factors are associated with poor outcomes with biologics, underscoring the need for lifestyle management. Effect sizes suggest that these factors alone cannot inform treatment selection.
Keyphrases
- rheumatoid arthritis
- randomized controlled trial
- cross sectional
- healthcare
- systematic review
- metabolic syndrome
- clinical trial
- physical activity
- cardiovascular disease
- mental health
- weight loss
- atopic dermatitis
- type diabetes
- double blind
- skeletal muscle
- combination therapy
- adipose tissue
- replacement therapy
- hidradenitis suppurativa